GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pure Health Holding PJSC (ADX:PUREHEALTH) » Definitions » Debt-to-EBITDA

Pure Health Holding PJSC (ADX:PUREHEALTH) Debt-to-EBITDA : 1.30 (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Pure Health Holding PJSC Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Pure Health Holding PJSC's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was د.إ50 Mil. Pure Health Holding PJSC's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was د.إ1,912 Mil. Pure Health Holding PJSC's annualized EBITDA for the quarter that ended in Sep. 2023 was د.إ1,514 Mil. Pure Health Holding PJSC's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was 1.30.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Pure Health Holding PJSC's Debt-to-EBITDA or its related term are showing as below:

ADX:PUREHEALTH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.41   Med: 0.41   Max: 1.08
Current: 1.08

During the past 2 years, the highest Debt-to-EBITDA Ratio of Pure Health Holding PJSC was 1.08. The lowest was 0.41. And the median was 0.41.

ADX:PUREHEALTH's Debt-to-EBITDA is ranked better than
68.96% of 422 companies
in the Healthcare Providers & Services industry
Industry Median: 2.59 vs ADX:PUREHEALTH: 1.08

Pure Health Holding PJSC Debt-to-EBITDA Historical Data

The historical data trend for Pure Health Holding PJSC's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Health Holding PJSC Debt-to-EBITDA Chart

Pure Health Holding PJSC Annual Data
Trend Dec21 Dec22
Debt-to-EBITDA
N/A 0.41

Pure Health Holding PJSC Quarterly Data
Sep22 Dec22 Sep23
Debt-to-EBITDA - 0.33 1.30

Competitive Comparison of Pure Health Holding PJSC's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Pure Health Holding PJSC's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Health Holding PJSC's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pure Health Holding PJSC's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pure Health Holding PJSC's Debt-to-EBITDA falls into.



Pure Health Holding PJSC Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Pure Health Holding PJSC's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(153.274 + 1749.434) / 4668.883
=0.41

Pure Health Holding PJSC's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(50.308 + 1911.977) / 1514.088
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.


Pure Health Holding PJSC  (ADX:PUREHEALTH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Pure Health Holding PJSC Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pure Health Holding PJSC's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Pure Health Holding PJSC (ADX:PUREHEALTH) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Aldar Headquarters building, Al Rahah Street, Abu Dhabi, ARE
Pure Health Holding PJSC is a integrated healthcare company in the United Arab Emirates with a cross category ecosystem covering hospitals, clinics, diagnostics, insurance, pharmacies, research, health tech, procurement along with an international footprint in the United States and the United Kingdom.

Pure Health Holding PJSC (ADX:PUREHEALTH) Headlines

No Headlines